Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

Treatment with (neo)adjuvant chemotherapy for breast cancer, as currently given, causes cell damage by induction of double-strand DNA breaks. Because BRCA1 and BRCA2 proteins play a role in the repair of DNA damage, the efficacy of (neo)adjuvant chemotherapy may be increased in BRCA1/2-associated br...

Descripción completa

Detalles Bibliográficos
Autores principales: Drooger, Jan C., Heemskerk-Gerritsen, Bernadette A. M., Smallenbroek, Nyrée, Epskamp, Cynthia, Seynaeve, Caroline M., Jager, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837227/
https://www.ncbi.nlm.nih.gov/pubmed/27060914
http://dx.doi.org/10.1007/s10549-016-3777-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837227/
https://www.ncbi.nlm.nih.gov/pubmed/27060914
http://dx.doi.org/10.1007/s10549-016-3777-0

Ejemplares similares